Skip to content

Digital Long-term Follow-up of Patients With Coronary Artery Disease

Digital Long-term Follow-up of Patients With Coronary Artery Disease: a Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07720349
Acronym
HeartCheck
Enrollment
630
Registered
2026-07-22
Start date
2026-04-01
Completion date
2029-12-01
Last updated
2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

coronary artery disease, secondary prevention, digital application

Brief summary

The need for better follow-up of AMI patients combined with recent developments in the digital area prompted the Department of Cardiology (HJE) at Oslo University Hospital (OUS) Ullevål, in collaboration with the Department of Digital Health Research (DIG) at OUS to develop a digital solution for long-term follow-up after AMI. The overall goal of the digital solution is to increase knowledge and awareness about important lifestyle measures and CV risk factors in patients who have survived an AMI, and to make it easy for the patients to monitor their own risk factors and attainment of treatment goals during long-term follow-up. Further, the HeartCheck seeks to provide guidance to ensure medication adherence. In this project, we study whether this newly developed app (HeartCheck), through education, regular reminders and easily understandable goals for secondary prevention, can improve risk factor control and drug adherence during long-term follow-up after AMI. A randomized controlled trial (RCT) is the chosen study design, being the gold standard for testing effectiveness of interventions.

Interventions

DEVICE"HeartCheck"

a digital application developed specifically for patient support during follow-up after acute myocardial infarction or PI for stable coronary artery disease

Sponsors

Oslo University Hospital
Lead SponsorOTHER
Sorlandet Hospital HF
CollaboratorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>18 years of age * survived a recent (\<30 days) AMI and/or PCI * access to a smartphone or tablet * signed written informed consent

Exclusion criteria

* patient does not understand Norwegian * patient is unable to comply with the study procedures due to severe comorbidities or high age

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients fulfilling 4 evidence-based goals for risk factor control12 months after inclusion in the studyProportion of patients who fulfills all of the following: 1) BP \<130/80 mmHg, 2) LDL-cholesterol \<1.4 mmol/l, 3) HbA1c \<53mmol/mol, 4) No smoking

Countries

Norway

Contacts

CONTACTSigrun Halvorsen
sigruha@uio.no+4722119101
CONTACTIda O Nilsen
PRINCIPAL_INVESTIGATORSigrun Halvorsen

Oslo University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026